Re-engagement in evidence-based quitline treatment for low income smokers

低收入吸烟者重新接受循证戒烟热线治疗

基本信息

  • 批准号:
    7741625
  • 负责人:
  • 金额:
    $ 16.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Tobacco dependence is a chronic relapsing condition that usually requires repeat quit attempts from tobacco users and long-term behavioral and pharmacotherapy support to achieve long term abstinence. Unfortunately, most cessation programs are not designed to treat tobacco use as a chronic condition and offer only one-time treatments with a finite period of intervention. Low income smokers face even more challenges in benefiting from this "one-shot" approach, as their relapse rates are typically higher than average, due in part to obstacles related to maintaining behavioral change while working and socializing in environments that are more conducive to tobacco use. Quitlines typically serve a large proportion of low-income smokers and are often the only source of tobacco cessation support available to this population. An intervention that targets low income smokers to re-engage in quitline treatment could have great public health impact by exposing this hard to quit group to additional opportunities to receive customized, evidence-based telephone- based tobacco cessation treatment. Interactive voice response (IVR) systems are capable of proactively contacting individuals and can be programmed to provide targeted motivational and informational messages. The primary aims of this research are to 1) Develop an IVR system that delivers tailored audio messages to increase smokers' re-engagement in treatment offered by two state quit lines and 2) Evaluate the feasibility and efficacy of an IVR system as a tool to reengage smokers into quitline treatment measured by number of IVR calls answered, number of smokers who re-engage in treatment and satisfaction with IVR calls. A secondary aim of this research is to obtain preliminary evidence of the efficacy of proactively re-engaging low income smokers into treatment on abstinence as compared to usual care. In the development phase of this proposal, smokers who have used quitline support in a previous quit attempt will be recruited and interviewed by telephone to support the development of tailored messages to encourage re-engagement in treatment among low income smokers. In the second phase, a randomized control trial will be conducted, with a sample of 3,000 smokers who used services from two state quitlines. Participants in the trial will be randomized to either receive usual care (no intervention to increase re-engagement) or the IVR intervention to increase re- engagement in treatment. Re-engagement in quitline treatment and quit rates will be measured at six month follow up. PUBLIC HEALTH RELEVANCE: In this study we will develop and test an Interactive Voice Response (IVR) intervention to increase re-engagement in treatment among low income smokers who had used quitline support in a past quit attempt. Intervention will be developed with input of low income smokers and its feasibility, acceptability and its preliminary efficacy tested in a randomized control trial.
描述(由申请人提供):烟草依赖性是一种慢性复发状况,通常需要从烟草使用者和长期行为和药物治疗支持中重复戒烟,以实现长期禁欲。不幸的是,大多数戒烟计划并非旨在将烟草用作慢性疾病,而仅提供有限的干预期治疗。低收入的吸烟者在从这种“单发”方法中受益的挑战中面临更多的挑战,因为他们的复发率通常高于平均水平,部分原因是与在更有利于烟草使用的环境中工作和社交相关的障碍。戒烟线通常为大量的低收入吸烟者提供服务,通常是该人群可用的戒烟支持的唯一来源。针对低收入吸烟者重新参与戒烟线治疗的一种干预措施,可以通过将这个难以退出的小组带给获得额外的机会,以获得额外的机会,从而获得额外的公共卫生影响。交互式语音响应(IVR)系统能够主动与个人联系,并且可以编程以提供有针对性的动机和信息信息。 The primary aims of this research are to 1) Develop an IVR system that delivers tailored audio messages to increase smokers' re-engagement in treatment offered by two state quit lines and 2) Evaluate the feasibility and efficacy of an IVR system as a tool to reengage smokers into quitline treatment measured by number of IVR calls answered, number of smokers who re-engage in treatment and satisfaction with IVR calls.这项研究的次要目的是获得初步证据证明,与通常的护理相比,主动将低收入吸烟者重新吸烟者戒酒的有效性。在该提案的发展阶段,将在先前的戒烟尝试中使用Quitline支持的吸烟者将通过电话招募和采访,以支持开发量身定制的信息,以鼓励在低收入吸烟者中重新接收治疗。在第二阶段,将进行一项随机对照试验,样本中有3,000名吸烟者使用了两种州戒烟的服务。试验的参与者将被随机接受常规护理(无需干预以增加重新参与)或IVR干预以增加治疗的重新参与。戒烟治疗和退出率的重新参与将在六个月的随访中衡量。 公共卫生相关性:在这项研究中,我们将开发和测试一种互动语音反应(IVR)干预措施,以增加在过去的戒烟尝试中使用Quitline支持的低收入吸烟者中的治疗重新参与。在一项随机对照试验中,将通过低收入吸烟者的投入及其可行性,可接受性及其初步疗效来开发干预措施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

POWS for NOWS: Using physiomarkers as an objective tool for assessing the withdrawing infant
POWS for NOWS:使用生理标志物作为评估退缩婴儿的客观工具
  • 批准号:
    10740629
    10740629
  • 财政年份:
    2023
  • 资助金额:
    $ 16.96万
    $ 16.96万
  • 项目类别:
Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery via Primary Care
主动戒烟电子就诊的混合 1 型有效性实施试验,通过初级保健进行可扩展交付
  • 批准号:
    10365698
    10365698
  • 财政年份:
    2022
  • 资助金额:
    $ 16.96万
    $ 16.96万
  • 项目类别:
Treatment Effect Heterogeneity in Psychosocial Treatments for Substance Use Disorders
药物使用障碍心理社会治疗的治疗效果异质性
  • 批准号:
    10683066
    10683066
  • 财政年份:
    2022
  • 资助金额:
    $ 16.96万
    $ 16.96万
  • 项目类别:
Addressing Rural Cancer Disparities via Proactive Smoking Cessation Treatment within Primary Care: A Hybrid Type 1 Effectiveness-Implementation Trial of a Scalable Smoking Cessation Electronic Visit
通过初级保健中的主动戒烟治疗解决农村癌症差异:可扩展戒烟电子就诊的 1 型混合有效性实施试验
  • 批准号:
    10701074
    10701074
  • 财政年份:
    2022
  • 资助金额:
    $ 16.96万
    $ 16.96万
  • 项目类别:
A novel data-driven approach for personalizing smoking cessation pharmacotherapy
一种新的数据驱动的个性化戒烟药物治疗方法
  • 批准号:
    10437438
    10437438
  • 财政年份:
    2022
  • 资助金额:
    $ 16.96万
    $ 16.96万
  • 项目类别: